Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

Ekaterina Chigrinova, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Paola M V Rancoita, Jonathan C. Strefford, David Oscier, Kostas Stamatopoulos, Theodora Papadaki, Francoise Berger, Ken H. Young, Fiona Murray, Richard Rosenquist, Timothy Charles Greiner, Wing C. Chan, Ester M. Orlandi, Marco Lucioni, Roberto Marasca, Giorgio Inghirami, Marco LadettoFrancesco Forconi, Sergio Cogliatti, Hana Votavova, Steven H. Swerdlow, Stephan Stilgenbauer, Miguel A. Piris, Andras Matolcsy, Dominic Spagnolo, Eugene Nikitin, Alberto Zamò, Valter Gattei, Govind Bhagat, German Ott, Emanuele Zucca, Gianluca Gaidano, Francesco Bertoni

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Richter syndrome (RS) occurs in up to 15% of patients with chronic lymphocytic leukemia (CLL). Although RS, usually represented by the histologic transformation to a diffuse large B-cell lymphoma (DLBCL), is associated with a very poor outcome, especially when clonally related to the preexisting CLL, the mechanisms leading to RS have not been clarified. To better understand the pathogenesis of RS, we analyzed a series of cases including 59 RS, 28 CLL phase of RS, 315 CLL, and 127 de novo DLBCL. RS demonstrated a genomic complexity intermediate between CLL and DLBCL. Cell-cycle deregulation via inactivation of TP53 and of CDKN2A was a main mechanism in the histologic transformation from CLL phase, being present in approximately one half of the cases, and affected the outcome of the RS patients. A second major subgroup was characterized by the presence of trisomy 12 and comprised one third of the cases. Although RS shared some of the lesions seen in de novo DLBCL, its genomic profile was clearly separate. The CLL phase preceding RS had not a generalized increase in genomic complexity compared with untransformed CLL, but it presented clear differences in the frequency of specific genetic lesions.

Original languageEnglish (US)
Pages (from-to)2673-2682
Number of pages10
JournalBlood
Volume122
Issue number15
DOIs
StatePublished - Jan 1 2013

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Cells
Deregulation
Lymphoma, Large B-Cell, Diffuse
Trisomy
Cell Cycle

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Chigrinova, E., Rinaldi, A., Kwee, I., Rossi, D., Rancoita, P. M. V., Strefford, J. C., ... Bertoni, F. (2013). Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood, 122(15), 2673-2682. https://doi.org/10.1182/blood-2013-03-489518

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. / Chigrinova, Ekaterina; Rinaldi, Andrea; Kwee, Ivo; Rossi, Davide; Rancoita, Paola M V; Strefford, Jonathan C.; Oscier, David; Stamatopoulos, Kostas; Papadaki, Theodora; Berger, Francoise; Young, Ken H.; Murray, Fiona; Rosenquist, Richard; Greiner, Timothy Charles; Chan, Wing C.; Orlandi, Ester M.; Lucioni, Marco; Marasca, Roberto; Inghirami, Giorgio; Ladetto, Marco; Forconi, Francesco; Cogliatti, Sergio; Votavova, Hana; Swerdlow, Steven H.; Stilgenbauer, Stephan; Piris, Miguel A.; Matolcsy, Andras; Spagnolo, Dominic; Nikitin, Eugene; Zamò, Alberto; Gattei, Valter; Bhagat, Govind; Ott, German; Zucca, Emanuele; Gaidano, Gianluca; Bertoni, Francesco.

In: Blood, Vol. 122, No. 15, 01.01.2013, p. 2673-2682.

Research output: Contribution to journalArticle

Chigrinova, E, Rinaldi, A, Kwee, I, Rossi, D, Rancoita, PMV, Strefford, JC, Oscier, D, Stamatopoulos, K, Papadaki, T, Berger, F, Young, KH, Murray, F, Rosenquist, R, Greiner, TC, Chan, WC, Orlandi, EM, Lucioni, M, Marasca, R, Inghirami, G, Ladetto, M, Forconi, F, Cogliatti, S, Votavova, H, Swerdlow, SH, Stilgenbauer, S, Piris, MA, Matolcsy, A, Spagnolo, D, Nikitin, E, Zamò, A, Gattei, V, Bhagat, G, Ott, G, Zucca, E, Gaidano, G & Bertoni, F 2013, 'Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome', Blood, vol. 122, no. 15, pp. 2673-2682. https://doi.org/10.1182/blood-2013-03-489518
Chigrinova E, Rinaldi A, Kwee I, Rossi D, Rancoita PMV, Strefford JC et al. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood. 2013 Jan 1;122(15):2673-2682. https://doi.org/10.1182/blood-2013-03-489518
Chigrinova, Ekaterina ; Rinaldi, Andrea ; Kwee, Ivo ; Rossi, Davide ; Rancoita, Paola M V ; Strefford, Jonathan C. ; Oscier, David ; Stamatopoulos, Kostas ; Papadaki, Theodora ; Berger, Francoise ; Young, Ken H. ; Murray, Fiona ; Rosenquist, Richard ; Greiner, Timothy Charles ; Chan, Wing C. ; Orlandi, Ester M. ; Lucioni, Marco ; Marasca, Roberto ; Inghirami, Giorgio ; Ladetto, Marco ; Forconi, Francesco ; Cogliatti, Sergio ; Votavova, Hana ; Swerdlow, Steven H. ; Stilgenbauer, Stephan ; Piris, Miguel A. ; Matolcsy, Andras ; Spagnolo, Dominic ; Nikitin, Eugene ; Zamò, Alberto ; Gattei, Valter ; Bhagat, Govind ; Ott, German ; Zucca, Emanuele ; Gaidano, Gianluca ; Bertoni, Francesco. / Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. In: Blood. 2013 ; Vol. 122, No. 15. pp. 2673-2682.
@article{a79a3b01cc3d4b88acb8810df7560e88,
title = "Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome",
abstract = "Richter syndrome (RS) occurs in up to 15{\%} of patients with chronic lymphocytic leukemia (CLL). Although RS, usually represented by the histologic transformation to a diffuse large B-cell lymphoma (DLBCL), is associated with a very poor outcome, especially when clonally related to the preexisting CLL, the mechanisms leading to RS have not been clarified. To better understand the pathogenesis of RS, we analyzed a series of cases including 59 RS, 28 CLL phase of RS, 315 CLL, and 127 de novo DLBCL. RS demonstrated a genomic complexity intermediate between CLL and DLBCL. Cell-cycle deregulation via inactivation of TP53 and of CDKN2A was a main mechanism in the histologic transformation from CLL phase, being present in approximately one half of the cases, and affected the outcome of the RS patients. A second major subgroup was characterized by the presence of trisomy 12 and comprised one third of the cases. Although RS shared some of the lesions seen in de novo DLBCL, its genomic profile was clearly separate. The CLL phase preceding RS had not a generalized increase in genomic complexity compared with untransformed CLL, but it presented clear differences in the frequency of specific genetic lesions.",
author = "Ekaterina Chigrinova and Andrea Rinaldi and Ivo Kwee and Davide Rossi and Rancoita, {Paola M V} and Strefford, {Jonathan C.} and David Oscier and Kostas Stamatopoulos and Theodora Papadaki and Francoise Berger and Young, {Ken H.} and Fiona Murray and Richard Rosenquist and Greiner, {Timothy Charles} and Chan, {Wing C.} and Orlandi, {Ester M.} and Marco Lucioni and Roberto Marasca and Giorgio Inghirami and Marco Ladetto and Francesco Forconi and Sergio Cogliatti and Hana Votavova and Swerdlow, {Steven H.} and Stephan Stilgenbauer and Piris, {Miguel A.} and Andras Matolcsy and Dominic Spagnolo and Eugene Nikitin and Alberto Zam{\`o} and Valter Gattei and Govind Bhagat and German Ott and Emanuele Zucca and Gianluca Gaidano and Francesco Bertoni",
year = "2013",
month = "1",
day = "1",
doi = "10.1182/blood-2013-03-489518",
language = "English (US)",
volume = "122",
pages = "2673--2682",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "15",

}

TY - JOUR

T1 - Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

AU - Chigrinova, Ekaterina

AU - Rinaldi, Andrea

AU - Kwee, Ivo

AU - Rossi, Davide

AU - Rancoita, Paola M V

AU - Strefford, Jonathan C.

AU - Oscier, David

AU - Stamatopoulos, Kostas

AU - Papadaki, Theodora

AU - Berger, Francoise

AU - Young, Ken H.

AU - Murray, Fiona

AU - Rosenquist, Richard

AU - Greiner, Timothy Charles

AU - Chan, Wing C.

AU - Orlandi, Ester M.

AU - Lucioni, Marco

AU - Marasca, Roberto

AU - Inghirami, Giorgio

AU - Ladetto, Marco

AU - Forconi, Francesco

AU - Cogliatti, Sergio

AU - Votavova, Hana

AU - Swerdlow, Steven H.

AU - Stilgenbauer, Stephan

AU - Piris, Miguel A.

AU - Matolcsy, Andras

AU - Spagnolo, Dominic

AU - Nikitin, Eugene

AU - Zamò, Alberto

AU - Gattei, Valter

AU - Bhagat, Govind

AU - Ott, German

AU - Zucca, Emanuele

AU - Gaidano, Gianluca

AU - Bertoni, Francesco

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Richter syndrome (RS) occurs in up to 15% of patients with chronic lymphocytic leukemia (CLL). Although RS, usually represented by the histologic transformation to a diffuse large B-cell lymphoma (DLBCL), is associated with a very poor outcome, especially when clonally related to the preexisting CLL, the mechanisms leading to RS have not been clarified. To better understand the pathogenesis of RS, we analyzed a series of cases including 59 RS, 28 CLL phase of RS, 315 CLL, and 127 de novo DLBCL. RS demonstrated a genomic complexity intermediate between CLL and DLBCL. Cell-cycle deregulation via inactivation of TP53 and of CDKN2A was a main mechanism in the histologic transformation from CLL phase, being present in approximately one half of the cases, and affected the outcome of the RS patients. A second major subgroup was characterized by the presence of trisomy 12 and comprised one third of the cases. Although RS shared some of the lesions seen in de novo DLBCL, its genomic profile was clearly separate. The CLL phase preceding RS had not a generalized increase in genomic complexity compared with untransformed CLL, but it presented clear differences in the frequency of specific genetic lesions.

AB - Richter syndrome (RS) occurs in up to 15% of patients with chronic lymphocytic leukemia (CLL). Although RS, usually represented by the histologic transformation to a diffuse large B-cell lymphoma (DLBCL), is associated with a very poor outcome, especially when clonally related to the preexisting CLL, the mechanisms leading to RS have not been clarified. To better understand the pathogenesis of RS, we analyzed a series of cases including 59 RS, 28 CLL phase of RS, 315 CLL, and 127 de novo DLBCL. RS demonstrated a genomic complexity intermediate between CLL and DLBCL. Cell-cycle deregulation via inactivation of TP53 and of CDKN2A was a main mechanism in the histologic transformation from CLL phase, being present in approximately one half of the cases, and affected the outcome of the RS patients. A second major subgroup was characterized by the presence of trisomy 12 and comprised one third of the cases. Although RS shared some of the lesions seen in de novo DLBCL, its genomic profile was clearly separate. The CLL phase preceding RS had not a generalized increase in genomic complexity compared with untransformed CLL, but it presented clear differences in the frequency of specific genetic lesions.

UR - http://www.scopus.com/inward/record.url?scp=84891038503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891038503&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-03-489518

DO - 10.1182/blood-2013-03-489518

M3 - Article

C2 - 24004666

AN - SCOPUS:84891038503

VL - 122

SP - 2673

EP - 2682

JO - Blood

JF - Blood

SN - 0006-4971

IS - 15

ER -